obesity drug glp-1 news today Market Overview: Agonists and the Market | Blog GLP-1 Weight-Loss Drug Demonstration Begins

Naotaifang formula attenuates OGD/R-induced inflammation and ferroptosis by regulating microglial M1/M2 polarization through BMP6/SMADs signaling pathway

J Clin Transl Res 2018;3:297310

Unlike the gold-standard Levodopa, which primarily alleviates symptoms but paradoxically generates iatrogenic ROS through auto-oxidation (Scigliano et al., 1997), bilirubin acts as an endogenous disease-modifying agent that specifically neutralizes such oxidative burdens (Jayanti et al., 2021)

Simon, A., et al

Deciphering biochemical basis of Qingkailing injection-induced anaphylaxis in a rat model by time-dependent metabolomic profiling based on metabolite polarity-oriented analysis

The Ingredient Strategy